Harbin Pharmaceutical Group Co., Ltd. (600664.SS)

2.6100 -0.0600 (-2.25%) At close: 02:47PM CST

Harbin Pharmaceutical Group Co., Ltd.

No. 7, Qunli Avenue
Daoli District
Harbin 150070
China
86 45 1518 70240
https://www.hayao.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 9,853

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Bo Jiang	CFO & VP	N/A	N/A	1964
Mr. Xiaodong Meng	VP & Secretary	N/A	N/A	1972
Mr. Haitao Jiang	Vice President	N/A	N/A	1982
Mr. Jicheng Xia	Vice President	N/A	N/A	1979
Mr. Bangdong Li	Vice President	N/A	N/A	1973

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and trading of pharmaceuticals in China and internationally. The company offers pharmaceutical products for blood and hematopoietic, antineoplastic and immunomodulatory, respiratory, anti-inflammatory and analgesic, and chronic diseases, as well as mineral supplements, Chinese medicines, and antibiotics. It offers its products under the Harbin Pharmaceutical, Sanjing, Gaizhonggai, Hutong, and Shiyitang brands. The company is based in Harbin, China.

Corporate governance

Harbin Pharmaceutical Group Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.